ZA973892B - Carbohydrate derivatives - Google Patents

Carbohydrate derivatives

Info

Publication number
ZA973892B
ZA973892B ZA973892A ZA973892A ZA973892B ZA 973892 B ZA973892 B ZA 973892B ZA 973892 A ZA973892 A ZA 973892A ZA 973892 A ZA973892 A ZA 973892A ZA 973892 B ZA973892 B ZA 973892B
Authority
ZA
South Africa
Prior art keywords
carbohydrate derivatives
carbohydrate
derivatives
Prior art date
Application number
ZA973892A
Other languages
English (en)
Inventor
Constant Adriaan A Van Boeckel
Pieter Westerduin
Original Assignee
Akzo Nobel Nv
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Sa filed Critical Akzo Nobel Nv
Publication of ZA973892B publication Critical patent/ZA973892B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA973892A 1996-05-08 1997-05-06 Carbohydrate derivatives ZA973892B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201267 1996-05-08

Publications (1)

Publication Number Publication Date
ZA973892B true ZA973892B (en) 1998-08-19

Family

ID=8223964

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA973892A ZA973892B (en) 1996-05-08 1997-05-06 Carbohydrate derivatives

Country Status (27)

Country Link
US (1) US5872110A (fr)
EP (1) EP0818459B1 (fr)
JP (1) JP4201360B2 (fr)
KR (1) KR100443802B1 (fr)
CN (1) CN1115345C (fr)
AR (1) AR007052A1 (fr)
AT (1) ATE215547T1 (fr)
AU (1) AU711630B2 (fr)
BR (1) BRPI9703099B8 (fr)
CA (1) CA2204204C (fr)
CZ (1) CZ292439B6 (fr)
DE (1) DE69711505T2 (fr)
DK (1) DK0818459T3 (fr)
ES (1) ES2176609T3 (fr)
HK (1) HK1004399A1 (fr)
HU (1) HU226370B1 (fr)
ID (1) ID17932A (fr)
IL (1) IL120722A (fr)
NO (1) NO308251B1 (fr)
NZ (1) NZ314745A (fr)
PL (1) PL183469B1 (fr)
PT (1) PT818459E (fr)
RU (1) RU2183638C2 (fr)
SG (2) SG55310A1 (fr)
TR (1) TR199700354A2 (fr)
TW (1) TW498078B (fr)
ZA (1) ZA973892B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE307596T1 (de) * 1997-05-27 2005-11-15 Sanofi Aventis Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
JP4369052B2 (ja) 1998-06-17 2009-11-18 ナームローゼ・フエンノートチヤツプ・オルガノン 抗血栓症化合物
HUP0201712A3 (en) * 1999-06-30 2003-03-28 Weitz Jeffrey I Ancaster Clot associated coagulation factors inhibiting heparin compositions
DE20022960U1 (de) * 1999-11-12 2002-07-25 Emisphere Technologies, Inc., Tarrytown, N.Y. Flüssige Heparinformulierung
US8600783B2 (en) * 2000-08-18 2013-12-03 The Crawford Group, Inc. Business to business computer system for communicating and processing rental car reservations using web services
JP2004507562A (ja) * 2000-09-08 2004-03-11 ハミルトン　シビック　ホスピタルズ　リサーチ　ディベロップメント　インコーポレイテッド 抗血栓性組成物
CN109134554B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134553B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134555B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN111057115B (zh) * 2019-12-17 2022-03-22 广东海洋大学 一种从贵妃蚌中提取的抗血栓类肝素及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (fr) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharides
ES2060284T3 (es) * 1990-04-23 1994-11-16 Sanofi Elf Un procedimiento para la preparacion de un derivado de carbohidrato que comprende una unidad de trisacarido.
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AU711630B2 (en) 1999-10-21
EP0818459B1 (fr) 2002-04-03
DK0818459T3 (da) 2002-07-01
PL319843A1 (en) 1997-11-10
HU226370B1 (en) 2008-09-29
BRPI9703099B8 (pt) 2021-07-06
SG55310A1 (en) 1998-12-21
BRPI9703099B1 (pt) 2016-07-19
ATE215547T1 (de) 2002-04-15
ID17932A (id) 1998-02-12
AU2008697A (en) 1997-11-13
DE69711505T2 (de) 2002-09-26
EP0818459A3 (fr) 1998-04-29
NO972120L (no) 1997-11-10
TR199700354A3 (tr) 1997-11-21
DE69711505D1 (de) 2002-05-08
KR19980018097A (ko) 1998-06-05
CZ292439B6 (cs) 2003-09-17
CN1169433A (zh) 1998-01-07
IL120722A0 (en) 1997-08-14
TR199700354A2 (xx) 1997-11-21
AR007052A1 (es) 1999-10-13
TW498078B (en) 2002-08-11
PL183469B1 (pl) 2002-06-28
CZ138697A3 (cs) 1998-02-18
RU2183638C2 (ru) 2002-06-20
NZ314745A (en) 1998-09-24
KR100443802B1 (ko) 2004-10-08
HUP9700852A2 (en) 1997-12-29
CN1115345C (zh) 2003-07-23
HK1004399A1 (en) 1998-11-27
NO972120D0 (no) 1997-05-07
HU9700852D0 (en) 1997-06-30
SG46779A1 (en) 1998-01-20
ES2176609T3 (es) 2002-12-01
MX9703365A (es) 1998-06-30
EP0818459A2 (fr) 1998-01-14
JP4201360B2 (ja) 2008-12-24
US5872110A (en) 1999-02-16
PT818459E (pt) 2002-08-30
CA2204204C (fr) 2006-02-28
BRPI9703099A (pt) 1998-09-08
NO308251B1 (no) 2000-08-21
IL120722A (en) 1999-07-14
JPH1045805A (ja) 1998-02-17
CA2204204A1 (fr) 1997-11-08
HUP9700852A3 (en) 1998-08-28

Similar Documents

Publication Publication Date Title
AP9700954A0 (en) 6-ohenylpyridyl-2-amine derivatives
ZA9710906B (en) 6-Phenylpyridyl-2-amine derivatives
NZ330954A (en) 19-nor-pregnene derivatives
ZA974053B (en) Alkylaminobenzothiazole and -benzoxazole derivatives
ZA9810559B (en) Carbohydrate derivatives
HUP9701835A3 (en) Vinyl-pirrolidinone-cephalosporin derivatives
GB2296495B (en) Anthracycline derivatives
IL129418A0 (en) 2-Methoxyphenylpiperazine derivatives
HU9700852D0 (en) Carbohydrate derivatives
IL125149A0 (en) Pyrazol-4-yl-hetaroyl derivatives
PL334558A1 (en) Cephalosporinic derivatives
HU9701479D0 (en) N-benzylazolium derivatives
ZA972051B (en) Benzodiazonine derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
GB9600063D0 (en) Guaridine derivatives
ZA971911B (en) 2-thioxo-tetrahydropyrimidin-4-one derivatives
IL130283A0 (en) Polysaccharide-peptide derivatives
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives
HU9601036D0 (en) Aryl-sulfonyl-hydroxamic-acid derivatives
EG23813A (en) Carbohydrate derivatives
GB9622832D0 (en) Sordarin derivatives
ZA971502B (en) Pyrazol-4-yl-hetaroyl derivatives
ZA97172B (en) Heterocycle-condensed morphinoid derivatives
IL145864A0 (en) Benzothiophenecarboxamide derivatives
ZA972808B (en) aminodihydropyridine derivatives